Lexicon Pharmaceuticals (LXRX) Capital Expenditures Growth (1y) (2011 - 2024)
Lexicon Pharmaceuticals (LXRX) Capital Expenditures Growth (1y) (2011 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Lexicon Pharmaceuticals |
804.48 Mn |
633.82 Mn |
20.99 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2024 |
269.88% |
| Jun 30, 2024 |
79.86% |
| Sep 30, 2023 |
1,975.00% |
| Mar 31, 2023 |
226.32% |
| Dec 31, 2022 |
5,317.39% |
| Sep 30, 2022 |
-98.12% |
| Mar 31, 2022 |
100.00% |
| Dec 31, 2021 |
-57.41% |
| Sep 30, 2021 |
545.45% |
| Mar 31, 2019 |
75.00% |
| Dec 31, 2018 |
825.00% |
| Sep 30, 2018 |
-95.08% |
| Jun 30, 2018 |
-78.87% |
| Mar 31, 2018 |
-56.52% |
| Dec 31, 2017 |
-97.30% |
| Sep 30, 2017 |
281.25% |
| Jun 30, 2017 |
446.15% |
| Mar 31, 2017 |
70.37% |
| Dec 31, 2016 |
-39.84% |
| Sep 30, 2016 |
-91.30% |
